Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Forest Road Acquisition Corp. FRX
$12.00
На 18:04, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
3745943940.00000000
-
week52high
18.20
-
week52low
9.24
-
Revenue
863582000
-
P/E TTM
-21
-
Beta
0.00000000
-
EPS
-
Last Dividend
0.00000000
-
Next Earnings Date
07 мая 2023 г. в 07:06
Описание компании
Forest Road Acquisition Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the technology, media, and telecommunications space. The company was founded in 2020 and is based in New York, New York.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| DA Davidson | Buy | 16 июн 2021 г. | |
| Loop Capital | Hold | 07 июн 2021 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
Fennec: Pedmark Approval Can Help Minimize Chemo-Induced Hearing Loss In Pediatric Cancer Patients
Seeking Alpha
24 окт 2022 г. в 03:52
After two CRLs, PEDMARK has finally been approved for preventing chemo-induced hearing loss in pediatric cancer patients. In addition to being both safe and effective, PEDMARK has not shown itself to interfere with the cancer-fighting properties of chemotherapy agents.
Buying Fennec Pharma Ahead Of September PDUFA For Pedmark
Seeking Alpha
22 авг 2022 г. в 23:37
PDUFA for Pedmark (sodium thiosulfate) in treating platinum chemotherapy-induced cytotoxicity (ear toxicity) in children is scheduled on September 23. The company resolved the issues raised in the second CRL within 3 months and announced the NDA acceptance in April this year.